Eid Parry India vs Sharda Cropchem: Share Price, Valuation and Results Compared

Eid Parry India Ltd (NSE: EIDPARRY) and Sharda Cropchem Ltd (NSE: SHARDACROP) are both listed in the Crop Protection Chemicals industry. Eid Parry India has a market capitalisation of ₹11,012 Cr and Sharda Cropchem ₹6,178 Cr, as of 9 Nov 2026. Their P/E ratios are 19.4 and 9.1 respectively. Return on equity is 9.91% for Eid Parry India and 24.16% for Sharda Cropchem. Over one year, Eid Parry India's share price is down 39.4% and Sharda Cropchem's is down 15.6%.

Eid Parry India vs Sharda Cropchem — Key Figures

MetricEid Parry IndiaSharda Cropchem
NSE SymbolEIDPARRYSHARDACROP
BSE Code500125538666
Share Price₹643.00₹689.00
Market Cap₹11,012 Cr₹6,178 Cr
P/E Ratio19.49.1
Return on Equity9.91%24.16%
Return on Assets6.26%8.90%
Dividend Yield0.00%2.63%
Beta (1Y)0.341.11
1-Year Price Change-39.4%-15.6%
3-Month Price Change-18.7%-15.2%
52-Week Range₹594.35 – ₹1,081.00₹622.50 – ₹1,297.00
Latest QuarterQ1 FY27Q2 FY27
Quarterly Revenue₹9,018 Cr₹1,052 Cr
Quarterly Net Profit₹312 Cr₹92 Cr
Net Margin3.5%8.7%
EPS (Basic, Quarter)₹7.96₹10.17
Results Basisconsolidatedconsolidated
HeadquartersChennai, Tamil NaduMumbai, Maharashtra

The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.

About the Companies

Eid Parry India Ltd

E.I.D.- Parry (India) Limited, together with its subsidiaries, engages in the manufacture and sale of sugar, nutraceuticals, and distillery products in India, North America, Europe, and internationally. The company offers sugar for use in food, bakery, confectioneries, beverage, and pharmaceutical industries; and grains, such as millets and dhals, as well as rice. It also provides nutraceuticals products, such as organic spirulina and chlorella, carotenoid, astaxanthin, and lutein and zeaxanthin; and distillery products, including extra neutral alcohol, ethanol, etc. In addition, the company o…

Sharda Cropchem Ltd

Sharda Cropchem Limited, a crop protection chemical company, provides various formulations and generic active ingredients worldwide. It offers agrochemical products, including insecticides, fungicides, herbicides, veterinary drugs, plant growth regulators, fumigants, regulators, rodenticides, metalaxyl, propiconazole, phenthoate, pendimethalin, and dithianon; and biocides. The company also provides conveyor belts, such as textile ply, rough top, steel cord, chevron/pattern, elevator, sidewall, pipe, and PVC/PVG solid woven conveyor belts, as well as cotton transmission belts, PVC and polyureth…

Frequently Asked Questions

Which is larger by market cap, Eid Parry India or Sharda Cropchem?

Eid Parry India has a market capitalisation of ₹11,012 Cr, against ₹6,178 Cr for Sharda Cropchem as of 9 Nov 2026, about 1.8 times the size by market cap.

What is the P/E ratio of Eid Parry India and Sharda Cropchem?

Eid Parry India has a P/E of 19.4 and Sharda Cropchem a P/E of 9.1 as of 9 Nov 2026.

What is the return on equity of Eid Parry India and Sharda Cropchem?

Eid Parry India has a return on equity of 9.91% and Sharda Cropchem 24.16%.

How have Eid Parry India and Sharda Cropchem shares moved over one year?

Eid Parry India's share price is down 39.4% over one year and Sharda Cropchem's is down 15.6%.

What were the latest quarterly results of Eid Parry India and Sharda Cropchem?

Eid Parry India reported revenue of ₹9,018 Cr and net profit of ₹312 Cr for Q1 FY27. Sharda Cropchem reported revenue of ₹1,052 Cr and net profit of ₹92 Cr for Q2 FY27. Figures are parsed from each company's exchange filing.

Which industry are Eid Parry India and Sharda Cropchem in?

Both are classified under Fertilizers & Agri Chemicals > Fertilizers and Agricultural Chemicals > Crop Protection Chemicals on FinBizNet.

Is this comparison a recommendation to buy or sell Eid Parry India or Sharda Cropchem?

No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.

More Comparisons

More on FinBizNet

Data as of 9 Nov 2026. Descriptive market data only — not investment advice.